
### [NCIT:C80308](http://purl.obolibrary.org/obo/NCIT_C80308)
**Label:** Splenic B-Cell Lymphoma/Leukemia, Unclassifiable

**Subclasses:** [NCIT:C7401](http://purl.obolibrary.org/obo/NCIT_C7401) (Hairy Cell Leukemia Variant), [NCIT:C80309](http://purl.obolibrary.org/obo/NCIT_C80309) (Splenic Diffuse Red Pulp Small B-Cell Lymphoma), 

**Class expressions from DL-Learner:**

- [NCIT:C38727](http://purl.obolibrary.org/obo/NCIT_C38727) (Villous Lymphocyte) 56.25%
- [NCIT:C3384](http://purl.obolibrary.org/obo/NCIT_C3384) (Splenomegaly) 56.25%
- Thing 52.30%
- [NCIT:C38654](http://purl.obolibrary.org/obo/NCIT_C38654) (Bone Marrow and Blood Involvement) 41.61%
- [NCIT:C122602](http://purl.obolibrary.org/obo/NCIT_C122602) (Bone Marrow and Extramedullary Involvement) 41.61%
- [NCIT:C38654](http://purl.obolibrary.org/obo/NCIT_C38654) (Bone Marrow and Blood Involvement) and (not ([NCIT:C38372](http://purl.obolibrary.org/obo/NCIT_C38372) (CEBPA Gene Mutation))) 41.61%
- [NCIT:C38654](http://purl.obolibrary.org/obo/NCIT_C38654) (Bone Marrow and Blood Involvement) and (not ([NCIT:C38362](http://purl.obolibrary.org/obo/NCIT_C38362) (RUNX1 Gene Mutation))) 41.61%
- [NCIT:C38654](http://purl.obolibrary.org/obo/NCIT_C38654) (Bone Marrow and Blood Involvement) and (not ([NCIT:C3836](http://purl.obolibrary.org/obo/NCIT_C3836) (Infertility))) 41.61%
- [NCIT:C38654](http://purl.obolibrary.org/obo/NCIT_C38654) (Bone Marrow and Blood Involvement) and (not ([NCIT:C38350](http://purl.obolibrary.org/obo/NCIT_C38350) (del(4)(q12)))) 41.61%
- [NCIT:C38654](http://purl.obolibrary.org/obo/NCIT_C38654) (Bone Marrow and Blood Involvement) and (not ([NCIT:C38348](http://purl.obolibrary.org/obo/NCIT_C38348) (MSN-ALK Fusion Protein Expression))) 41.61%
- [NCIT:C38654](http://purl.obolibrary.org/obo/NCIT_C38654) (Bone Marrow and Blood Involvement) and (not ([NCIT:C38347](http://purl.obolibrary.org/obo/NCIT_C38347) (P13K-AKT Pathway Deregulation))) 41.61%
- [NCIT:C38654](http://purl.obolibrary.org/obo/NCIT_C38654) (Bone Marrow and Blood Involvement) and (not ([NCIT:C38346](http://purl.obolibrary.org/obo/NCIT_C38346) (MYC Pathway Deregulation))) 41.61%
- [NCIT:C38654](http://purl.obolibrary.org/obo/NCIT_C38654) (Bone Marrow and Blood Involvement) and (not ([NCIT:C38345](http://purl.obolibrary.org/obo/NCIT_C38345) (JUN Pathway Deregulation))) 41.61%
- [NCIT:C38654](http://purl.obolibrary.org/obo/NCIT_C38654) (Bone Marrow and Blood Involvement) and (not ([NCIT:C38344](http://purl.obolibrary.org/obo/NCIT_C38344) (RAS-RAF Pathway Deregulation))) 41.61%
- [NCIT:C38654](http://purl.obolibrary.org/obo/NCIT_C38654) (Bone Marrow and Blood Involvement) and (not ([NCIT:C38343](http://purl.obolibrary.org/obo/NCIT_C38343) (JAK-STAT Pathway Deregulation))) 41.61%


